Coronavirus update

Thank you for entrusting us with your health care. We understand the concern and uncertainty you may be feeling about coronavirus (also known as COVID-19). With your care and safety in mind, we are changing how we provide some services.

Your health and safety are our top priorities, today and every day. We are here to provide you with the care and support you need. We encourage you to stay informed about how to stay healthy and to learn what steps to take if you think you have COVID-19. For the most up-to-date information on Allina Health's coronavirus response, and the information you need to stay healthy, learn more here.


For more information
Call 612-863-3900
Durand Burns, MD, FACC mhi_logo

Pulmonary hypertension program

The Pulmonary hypertension program provides comprehensive assessment and management for all types of pulmonary hypertension. Extensive evaluation includes state-of-the-art invasive vasodilator testing.

Our specialized team provides 24-hour care for outpatient and urgent inpatient support. This dedicated team of professionals is committed to providing exceptional care and in-depth assistance for all aspects of this unique disease process.

Treatment options range from FDA-approved oral, inhaled, injectable and continuous IV therapies to involvement in research protocols from the latest clinical trials.

We provide assistance with reimbursement and insurance issues, and help connect patients with appropriate medication assistance programs, when needed.

Locations

Minneapolis Heart Institute® — Baxter

Minneapolis Heart Institute® — Crosby

Providers

Minneapolis Heart Institute providers are able to care for patients in every stage of pulmonary hypertension - from assisting with risk assessments to surgical treatment when necessary.

Cabuay Barry

Barry Cabuay, MD, FACC 
Director, Pulmonary Hypertension Program 

bio 128x177
Emily Anderson, RN